• 1. Distinct roles of SNARE-mimicking lipopeptides during initial steps of membrane fusion?
  Alena Koukalová,?árka Pokorná,Aimee L. Boyle,Nestor Lopez Mora,Alexander Kros,Martin Hof,Radek ?achl Nanoscale, 2018,10, 19064-19073
• 2. Excellent peroxidase mimicking property of CuO/Pt nanocomposites and their application as an ascorbic acid sensor?
  Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
• 3. Emerging investigators
  Polym. Chem., 2015,6, 5501-5502
• 4. Fe3O4 nanoparticle chains with N-doped carbon coating: magnetotactic bacteria assisted synthesis and high-rate lithium storage?
  Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962
• 5. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridines and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives

Thiazolo[5,4-c]pyridine: A Versatile Heterocyclic Compound with Promising Applications in Medicinal Chemistry

Thiazolo[5,4-c]pyridine (CAS No. 273-70-1) is a heterocyclic compound that has garnered significant attention in the field of medicinal chemistry due to its unique structural features and potential biological activities. This compound belongs to the class of thiazolopyridines, which are characterized by a fused thiazole and pyridine ring system. The thiazolo[5,4-c]pyridine scaffold has been extensively studied for its diverse pharmacological properties, including antimicrobial, anticancer, and anti-inflammatory activities.

The thiazolo[5,4-c]pyridine core is known for its ability to modulate various biological targets, making it a valuable scaffold for drug discovery and development. Recent research has highlighted the potential of thiazolo[5,4-c]pyridine derivatives in the treatment of various diseases, particularly in oncology and infectious diseases. For instance, a study published in the Journal of Medicinal Chemistry reported that certain thiazolo[5,4-c]pyridine derivatives exhibited potent antitumor activity against a panel of human cancer cell lines. These findings underscore the importance of thiazolo[5,4-c]pyridine as a lead structure for the development of novel therapeutic agents.

In addition to its anticancer properties, thiazolo[5,4-c]pyridine has shown promise in the treatment of infectious diseases. A recent study in the European Journal of Medicinal Chemistry demonstrated that thiazolo[5,4-c]pyridine derivatives exhibited significant antibacterial activity against both Gram-positive and Gram-negative bacteria. This broad-spectrum activity makes thiazolo[5,4-c]pyridine an attractive candidate for the development of new antibiotics to combat multidrug-resistant pathogens.

The structural versatility of thiazolo[5,4-c]pyridine allows for the introduction of various functional groups at different positions on the ring system. This flexibility enables chemists to fine-tune the pharmacological properties of the compound to meet specific therapeutic needs. For example, substituents such as halogens, alkyl groups, and aromatic rings can be introduced to enhance solubility, bioavailability, and target selectivity. The ability to modify the thiazolo[5,4-c]pyridine scaffold through synthetic chemistry has led to the discovery of numerous bioactive derivatives with improved pharmacological profiles.

One of the key challenges in drug development is optimizing the pharmacokinetic properties of lead compounds. Recent studies have focused on improving the metabolic stability and oral bioavailability of thiazolo[5,4-c]pyridine derivatives. A study published in Bioorganic & Medicinal Chemistry Letters reported that certain thiazolo[5,4-c]pyridine derivatives exhibited enhanced metabolic stability and improved oral bioavailability compared to their parent compounds. These findings highlight the importance of structure-activity relationship (SAR) studies in optimizing the pharmacokinetic properties of thiazolo[5,4-c]pyridine derivatives.

The biological activities of thiazolo[5,4-c]pyridine are not limited to its direct interaction with biological targets. Recent research has also explored the potential of thiazolo[5,4-c]pyridine as a photosensitizer for photodynamic therapy (PDT). A study published in Photochemistry and Photobiology demonstrated that certain thiazolo[5,4-c]pyridine derivatives exhibited excellent photophysical properties and could be used as effective photosensitizers for PDT applications. This dual functionality as both a direct therapeutic agent and a photosensitizer makes thiazolo[5,4-c]pyridine a versatile scaffold for developing multifunctional drugs.

In conclusion, Thiazolo[5,4-c]pyridine (CAS No. 273-70-1) is a promising heterocyclic compound with a wide range of potential applications in medicinal chemistry. Its unique structural features and diverse biological activities make it an attractive scaffold for drug discovery and development. Ongoing research continues to uncover new insights into the pharmacological properties and therapeutic potential of thiazolo[5,4-c]pyridine, paving the way for the development of novel therapeutic agents to address unmet medical needs.

• 95-16-9(Benzothiazole)
• 233-75-0(Thiazolo[4,5-f]quinoline(8CI,9CI))
• 269-25-0(Thiazolo[4,5-g]quinoline(8CI,9CI))
• 269-27-2(Thiazolo[5,4-g]quinoline(8CI,9CI))
• 193342-78-8(Thiazolo[5,4-g]isoquinoline(9CI))
• 193342-79-9(Thiazolo[4,5-g]isoquinoline(9CI))
• 234-48-0(Thiazolo[5,4-f]quinoline(8CI,9CI))
• 269-24-9(Naphtho[2,3-d]thiazole)
• 233-74-9(Naphtho[1,2-d]thiazole)
• 14635-33-7(Phenanthro[2,1-d]thiazole(8CI,9CI))